Hiv/Aids Infection
HIV Curbside Consults: Addressing Questions on Weight Gain and Desire for Injectable Therapy
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
HIV Curbside Consults: Treatment of Complex Patients with HIV
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
HIV Curbside Consults: Treating Patients With Multiple Comorbidities or Intolerance
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
HIV Curbside Consults: Treating Older Patients With HIV
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Study: Long-acting PrEP could reduce HIV incidence, AIDS deaths in sub-Saharan Africa
The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future AIDS deaths and new infections, while being a cost-effective alternative to oral PrEP, according to a recent study.
Prison program for HIV PrEP enrolls 93% of eligible people
A high percentage of eligible incarcerated persons voluntarily initiated HIV PrEP in a sub-Saharan Africa criminal justice setting, according to a study published in The Lancet HIV.
UNAIDS: Urgent action needed as global crises undermine HIV/AIDS response
In its annual report, UNAIDS said urgent action is needed to get the fight against HIV/AIDS back on track after it was derailed by “overlapping crises,” leaving up to 4,000 people with new HIV infections every day.
‘Breathtaking results’: Botswana hits UNAIDS 95-95-95 HIV targets
Botswana has achieved the UNAIDS 95-95-95 targets for people with HIV, according to data presented at the International AIDS Conference.
Six stories for HIV Vaccine Awareness Day
Globally, more than 37 million people are living with HIV, nearly two-thirds of them in Africa.
Adding maraviroc to standard treatment for advanced HIV does not improve outcomes
Adding maraviroc to a standard three-drug antiretroviral therapy regimen in patients with advanced HIV did not improve outcomes, according to research published in the Annals of Internal Medicine.